There are no cookie-cutter solutions
Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease
Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Many of the publications likely support the approximately 90,000 patent submissions registered in 2023
While primarily used for pattern hair loss, some clinicians may suggest minoxidil for telogen effluvium to support recovery, though this would be an off-label use and evidence is less established for this indication
Brand-name Wegovy and Zepbound list between $900 and over $1,500 per month without insurance